PharmaRadar360

PharmaRadar360

馃嚭馃嚫路13h agoRegulatoryTier 1 路 Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...

Publisher

F
Federal Register

USA

This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.

Read original

At a glance

Publisher
Federal Register
Region
USA
Scope
Regulatory
Published
September 29, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...

Source route

Continue on federalregister.gov

Leave the platform to read the original full article on the publisher site.

Source: Federal Register

Scope: Regulatory

Evidence: Tier 1 路 Regulatory source

Open original article
Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards | PharmaRadar360